ArticleMedical oncology (Northwood, London, England)2014

EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway.

Hongli Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.